CCL5 and glioblastoma: Studies exploring the gene expression distribution of CCR5 and CCL5 among different genetic GBM subtypes showed the highest CCR5 levels in the CL–GBM subtype and the lowest in MES–GBM subtype, wherein CD44-mediated signaling may be predominant [13].